Quarterly report pursuant to Section 13 or 15(d)

Common Stock and Employee Equity Plans (Tables)

v3.22.1
Common Stock and Employee Equity Plans (Tables) - USD ($)
shares in Millions, $ in Millions
 3 Months Ended
Mar. 26, 2022
Mar. 27, 2021
Equity [Abstract]    
Schedule of Common Shares Outstanding
Common Stock
Shares of common stock outstanding were as follows:
Three Months Ended
March 26,
2022		 March 27,
2021
(In millions)
Balance, beginning of period 1,207  1,211 
Common stock issued for the acquisition of Xilinx 429  — 
Common stock issued under employee equity plans 1  1 
Common stock repurchases for tax withholding on equity awards (1) — 
Issuance of common stock to settle convertible debt —  3 
Repurchases of common stock (16) — 
Balance, end of period 1,620  1,215 
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount
Stock-based Compensation
Stock-based compensation expense was recorded in the Condensed Consolidated Statements of Operations as follows: 
Three Months Ended
March 26,
2022		 March 27,
2021
(In millions)
Cost of sales $ 4  $ 1 
Research and development 113  55 
Marketing, general and administrative 82  29 
Total stock-based compensation expense before income taxes 199  85 
Income tax benefit (43) (13)
Total stock-based compensation expense after income taxes $ 156  $ 72 
 
Stock Repurchased During Period, Shares 15.8  
Payments for Repurchase of Common Stock $ 1,914 $ 0
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 8,300.0